Truist Financial Corp Decreases Stock Holdings in Agilent Technologies, Inc. $A

Truist Financial Corp decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 5.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 29,835 shares of the medical research company’s stock after selling 1,665 shares during the quarter. Truist Financial Corp’s holdings in Agilent Technologies were worth $3,521,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. JLB & Associates Inc. raised its holdings in shares of Agilent Technologies by 1.9% during the 2nd quarter. JLB & Associates Inc. now owns 29,652 shares of the medical research company’s stock worth $3,499,000 after acquiring an additional 540 shares during the period. Capital Investment Advisors LLC raised its stake in Agilent Technologies by 7.8% during the second quarter. Capital Investment Advisors LLC now owns 3,027 shares of the medical research company’s stock worth $357,000 after purchasing an additional 218 shares during the period. Northwest Wealth Management LLC purchased a new position in Agilent Technologies during the second quarter worth about $205,000. HB Wealth Management LLC raised its stake in Agilent Technologies by 7.2% during the second quarter. HB Wealth Management LLC now owns 8,138 shares of the medical research company’s stock worth $960,000 after purchasing an additional 546 shares during the period. Finally, Invesco LLC raised its stake in Agilent Technologies by 10.2% during the second quarter. Invesco LLC now owns 26,519 shares of the medical research company’s stock worth $3,130,000 after purchasing an additional 2,457 shares during the period.

Agilent Technologies Stock Performance

Shares of A opened at $140.81 on Thursday. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a market capitalization of $39.92 billion, a price-to-earnings ratio of 33.05, a PEG ratio of 4.52 and a beta of 1.26. The company’s 50 day simple moving average is $124.07 and its 200 day simple moving average is $116.81. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the business posted $1.32 earnings per share. The firm’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

Analyst Ratings Changes

Several research firms have recently commented on A. Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Evercore ISI lifted their target price on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday. Barclays boosted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. Finally, Wells Fargo & Company boosted their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $147.92.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.